Non-invasive MRI of mouse models of atherosclerosis

NMR in Biomedicine

Volumn 20, Issue 3, 2007, Pages 256-264

  Weinreb, David B ^a   Aguinaldo, Juan Gilberto S ^a   Feig, Jonathan E ^b   Fisher, Edward A ^b   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Mouse models; MRI

Indexed keywords

ANIMALS; HEMODYNAMICS; MATHEMATICAL MODELS; MEDICAL IMAGING; REGRESSION ANALYSIS;

ATHEROSCLEROSIS; MORBIDITY; MOUSE MODELS;

MAGNETIC RESONANCE IMAGING;

ADENOVIRUS VECTOR; APOLIPOPROTEIN E; BIOLOGICAL MARKER; DNA; GADOLINIUM; LIPID; MATRIX METALLOPROTEINASE; SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

AORTA ROOT; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR GENE THERAPY; CELL DIFFERENTIATION; DIAGNOSTIC ACCURACY; DISEASE COURSE; HISTOPATHOLOGY; LIPID ANALYSIS; MORPHOMETRICS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MICE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 34249737933     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1148     Document Type: Review

References (34)

1. American Heart Association. 2004; Heart disease and stroke statistics: 2004 update. http://www.americanheart.org/download-able/ heart/1079736729696HDSStats2OO4UpdateREV3-19-04.pdf (accessed 14 Feb 2007).
2. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
3. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adult: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J. Am. Coll. Cardiol. 1995; 26: 654-661.
4. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
5. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med. 1997; 336: 1276-1282.
6. Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, van der Steen AF. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004; 25: 1077-1082.
7. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000; 283: 3223-3229.
8. Hyafil F, Cornily JC, Feig J, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA. Non invasive detection of macrophages using a novel contrast agent for computed tomography. Nat. Med. 2007; in press.
9. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl. Acad. Sci. USA 2007; 104(3): 961-966.
10. Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M, Hotker MH. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin. Chem. Lab. Med. 2005; 43: 470-479.
11. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-353.
12. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 16; 258(5081): 468-471.
13. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive in vivo high resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 1998; 98: 1541-1547.
14. Trogan E, Fayad ZA, Itskovich VV, Aguinaldo JG, Mani V, Fallon JT, Chereshnev I, Fisher EA. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb. Vasc. Biol. 2004; 24: 1714-1719.
15. Itskovich VV, Choudhury RP, Aguinaldo JG, Fallon JT, Omerhodzic S, Fisher EA, Fayad ZA. Characterization of aortic root atherosclerosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRI with histological correlation. Magn. Reson. Med. 2003; 49: 381-385.
16. Chaabane L, Pellet N, Bourdillon MC, Desbleds Mansard C, Sulaiman A, Hadour G, Thivolet-Bejui F, Roy P, Briguet A, Douek P, Canet Soulas E. Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla. Magma 2004; 17: 188-195.
17. Schneider JE, McAteer MA, Tyler DJ, Clarke K, Channon KM, Choudhury RP, Neubauer S. High-resolution, multicontrast three dimensional-MRI characterizes atherosclerotic plaque composition in ApoE_/_mice ex vivo. J. Magn. Reson. Imaging 2004; 20: 981-989.
18. McAteer MA, Schneider JE, Clarke K, Neubauer S, Channon KM, Choudhury RP. Quantification and 3D reconstruction of atherosclerotic plaque components in apolipoprotein E knockout mice using ex vivo high-resolution MRI. Arterioscler Thromb. Vasc. Biol. 2004; 24: 2384-2390.
19. Hockings PD, Roberts T, Galloway GJ, Reid DG, Harris DA, Vidgeon-Hart M, Groot PH, Suckling KE, Benson GM. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor knockout mice. Circulation 2002; 106: 1716-1721.
20. Manka DR, Gilson W, Sarembock I, Ley K, Berr SS. Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the carotid artery of the apolipoprotein-E null mouse. J. Magn. Reson. Imaging 2000; 12: 790-794.
21. Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED, Fallon JT, Fuster V, Fisher EA, Fayad ZA. Atherosclerotic lesions in genetically modified mice quantified in vivo by noninvasive high-resolution magnetic resonance microscopy. Atherosclerosis 2002; 162: 315-321.
22. Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, Rosenfeld ME. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb. Vasc. Biol. 1997; 17: 3593-3601.
23. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 1987; 316: 1371-1375.
24. Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ. Serial in vivo MRI documents arterial remodelling in experimental atherosclerosis. Circulation 2002; 101: 586-589.
25. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 2000; 102: 1186-1191.
26. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc. Res. 2003; 59: 812-823.
27. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105: 2766-2771.
28. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1B, and interferon-gamma. Circulation 2003; 107: 1545-1549.
29. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 2005; 96: 327-336.
30. Tsukamoto K, Tangirala R, Chun SH, Pure E, Rader DJ. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb. Vasc. Biol. 1999; 19: 2162-2170.
31. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, Aguinaldo JG, Fallon JT, Fisher EA. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J. Vasc. Surg. 2001; 34: 541-547.
32. Chereshnev I, Trogan E, Omerhodzic S, Itskovich V, Aguinaldo JG, Fayad ZA, Fisher EA, Reis ED. Mouse model of heterotopic aortic arch transplantation. J Surg. Res. 2003; 111: 171-176.
33. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon A Charlton SA, Fisher EA, Brewslow JL, Fuster V. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 1998; 98: 1541-1547.
34. Choudhury RP, Fuster V, Fayad ZA, Molecular cellular and functional imaging of atherothrombosis. Nat. Rev. Drug Discov. 2004; 3: 913-925.